Yes-associated protein is dysregulated in human congenital diaphragmatic hernia patients during mid and end gestation
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Dec 2024 · 1 min read
In brief
In brief
This study examines Yes-associated protein (YAP) dysregulation in human CDH fetuses, finding elevated levels of inactive phosphorylated YAP throughout gestation. The research suggests this YAP inactivation disrupts normal lung development and cellular differentiation, providing molecular insights into CDH pathogenesis and potential therapeutic targets.
- YAP protein is dysregulated in CDH fetal lungs, with increased levels of inactive phosphorylated YAP (p-YAP) compared to controls.
- Elevated p-YAP in CDH suggests impaired YAP signaling may disrupt normal lung development during mid and end gestation.
- CDH lungs show altered cellular differentiation with more SPC-positive cells and fewer HOPX-positive cells at end-gestation.
- YAP dysregulation may be a key molecular mechanism underlying abnormal lung development in congenital diaphragmatic hernia.
Written by the GCMD Library team from the article.
Abstract
Background
Yes-associated protein (YAP) is implicated in congenital diaphragmatic hernia (CDH). This study aims to investigate the abundance of YAP and its inactive form, phosphorylated YAP (p-YAP), in fetal human lung tissues from CDH cases compared to control cases at mid-gestation and end-gestation.
Methods
Immunofluorescence was performed to assess the abundance of YAP and p-YAP in lung tissues from human CDH and control fetuses who died from causes other than CDH. Additionally, the impact on cellular differentiation was evaluated by assessing the expression of Homeodomain-only protein X (HOPX) and Surfactant protein C (SPC).
Results
Immunostaining revealed a higher abundance of YAP and p-YAP in both mid-gestation and end-gestation lung tissues. Notably, the abundance of p-YAP was increased in CDH tissues compared to controls, indicating higher levels of the inactive form of YAP in CDH. HOPX and SPC staining showed CDH tissues had a higher number of SPC-positive cells and fewer HOPX-positive cells at end-gestation.
Conclusions
Our findings suggest that in CDH, YAP is predominantly present in its inactive form, p-YAP, potentially disrupting normal lung development and differentiation. This underscores the potential involvement of YAP dysregulation in the pathogenesis of CDH.